Conditions, including, but not limited to:
- Arthritis:
- crystal
- infective or post-infective
- juvenile idiopathic arthritis
- psoriatic
- rheumatoid
- spondyloarthritis
For each presentation and condition, Advanced Trainees will know how to:
Synthesise
- recognise the clinical presentation
- identify relevant epidemiology, pathophysiology, and clinical science
- take a comprehensive clinical history
- conduct an appropriate examination
- establish a differential diagnosis
- plan and arrange appropriate investigation
- consider the impact of illness and disease on patients and families, and their quality of life
Manage
- provide evidence-based management
- prescribe therapies tailored to patients’ needs and conditions
- recognise potential complications of disease and its management, and initiate preventative strategies
- involve multidisciplinary teams
Consider other factors
- identify individual and social factors and the impact of these on diagnosis and management
- Synovitis, acne, pustulosis, hyperostosis and osteitis syndrome (SAPHO)
Synthesise
- recognise the clinical presentation
- identify relevant epidemiology, pathophysiology, and clinical science
- take a comprehensive clinical history
- conduct an appropriate examination
- establish a differential diagnosis
- plan and arrange appropriate investigation
- consider the impact of illness and disease on patients and families, and their quality of life
Manage
- provide evidence-based management
- prescribe therapies tailored to patients’ needs and conditions
- recognise potential complications of disease and its management, and initiate preventative strategies
- involve multidisciplinary teams
Consider other factors
- identify individual and social factors and the impact of these on diagnosis and management
- Fundamental epidemiology and pathophysiology of the principle arthritides
Therapeutics and management principles
- Pharmaceutical Benefits Scheme (PBS) / Pharmac prescribing
- Pharmacological and non-pharmacological management of pain from inflammatory disease
- Pharmacology and toxicity of immunosuppression
- Pharmacotherapeutic management of inflammatory disease, such as:
- biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs)
- conventional DMARDs
- glucocorticoids, including oral and intra-articular (IA), and long-term side effects
- gout therapy
- management of metabolic risk factors
- monitoring of potential drug-related complications and side effects
- Pre-immunosuppression screening and appropriate treatment or prophylaxis
- Selection of drug therapy or immunosuppression based on:
- local prescribing / funding restrictions
- patient factors
- severity of arthritis
- Clinical utility and limitations of laboratory tests for inflammatory arthritis
- Disease activity scores for various inflammatory arthritides
- Strengths and limitations of imaging in the diagnosis and management of inflammatory arthritis
Procedures
- Aspirate – joint, for synovial analysis
- Injection – intra-articular joint
- Genetic and cultural differences in the presentation and management of inflammatory arthritis
- Tailoring management of inflammatory arthritis to individual patients’ circumstances, such as:
- at end-of-life
- during preconception planning
- lactation
- old age
- pregnancy
- transitioning from paediatric care
